https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Resveratrol does not benefit patients with non-alcoholic fatty liver disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19484 Wed 04 Apr 2018 17:03:10 AEST ]]> High-intensity Interval Training for the Management of Nonalcoholic Steatohepatitis: Participant Experiences and Perspectives https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52502 Mon 16 Oct 2023 10:09:38 AEDT ]]> High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50931 Mon 14 Aug 2023 12:01:38 AEST ]]>